US20220125097A1 - Tobacco processing method - Google Patents
Tobacco processing method Download PDFInfo
- Publication number
- US20220125097A1 US20220125097A1 US17/436,846 US202017436846A US2022125097A1 US 20220125097 A1 US20220125097 A1 US 20220125097A1 US 202017436846 A US202017436846 A US 202017436846A US 2022125097 A1 US2022125097 A1 US 2022125097A1
- Authority
- US
- United States
- Prior art keywords
- tobacco material
- tobacco
- treated tobacco
- treated
- gases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 330
- 244000061176 Nicotiana tabacum Species 0.000 title description 8
- 238000003672 processing method Methods 0.000 title description 8
- 241000208125 Nicotiana Species 0.000 claims abstract description 324
- 239000000463 material Substances 0.000 claims abstract description 218
- 239000007789 gas Substances 0.000 claims abstract description 100
- 238000000034 method Methods 0.000 claims abstract description 91
- 230000009467 reduction Effects 0.000 claims abstract description 34
- 238000012545 processing Methods 0.000 claims abstract description 22
- 230000002441 reversible effect Effects 0.000 claims abstract description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 131
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 66
- 239000001569 carbon dioxide Substances 0.000 claims description 65
- 238000007789 sealing Methods 0.000 claims description 15
- 238000004806 packaging method and process Methods 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 89
- 229960002715 nicotine Drugs 0.000 description 89
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 89
- 239000007858 starting material Substances 0.000 description 81
- 239000000443 aerosol Substances 0.000 description 38
- 238000011282 treatment Methods 0.000 description 34
- 239000000796 flavoring agent Substances 0.000 description 29
- 235000019634 flavors Nutrition 0.000 description 22
- 239000013543 active substance Substances 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 239000008187 granular material Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 235000019505 tobacco product Nutrition 0.000 description 7
- 235000004357 Mentha x piperita Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 235000014749 Mentha crispa Nutrition 0.000 description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 5
- 239000003571 electronic cigarette Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 244000246386 Mentha pulegium Species 0.000 description 4
- 235000016257 Mentha pulegium Nutrition 0.000 description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 4
- 235000012550 Pimpinella anisum Nutrition 0.000 description 4
- 240000004760 Pimpinella anisum Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000218236 Cannabis Species 0.000 description 3
- 244000018436 Coriandrum sativum Species 0.000 description 3
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 3
- 240000006927 Foeniculum vulgare Species 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000014435 Mentha Nutrition 0.000 description 3
- 241001072983 Mentha Species 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 244000078639 Mentha spicata Species 0.000 description 3
- 241001479543 Mentha x piperita Species 0.000 description 3
- 235000009421 Myristica fragrans Nutrition 0.000 description 3
- 238000013494 PH determination Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003637 basic solution Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000001771 mentha piperita Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- KOCVACNWDMSLBM-UHFFFAOYSA-N 4-(Ethoxymethyl)-2-methoxyphenol Chemical compound CCOCC1=CC=C(O)C(OC)=C1 KOCVACNWDMSLBM-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- 240000006914 Aspalathus linearis Species 0.000 description 2
- -1 B6 or B12 or C Chemical compound 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 240000002943 Elettaria cardamomum Species 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 240000001238 Gaultheria procumbens Species 0.000 description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 2
- 241000208152 Geranium Species 0.000 description 2
- 235000008227 Illicium verum Nutrition 0.000 description 2
- 240000007232 Illicium verum Species 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 244000165082 Lavanda vera Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 244000182807 Mentha suaveolens Species 0.000 description 2
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 244000270834 Myristica fragrans Species 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- 235000008632 Santalum album Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000005300 cardamomo Nutrition 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 235000019506 cigar Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- 239000001220 mentha spicata Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000001702 nutmeg Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 210000003901 trigeminal nerve Anatomy 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QGDOQULISIQFHQ-UHFFFAOYSA-N 1,3,7,9-tetramethyluric acid Chemical compound CN1C(=O)N(C)C(=O)C2=C1N(C)C(=O)N2C QGDOQULISIQFHQ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 235000003320 Adansonia digitata Nutrition 0.000 description 1
- 244000056971 Adansonia gregorii Species 0.000 description 1
- 235000003319 Adansonia gregorii Nutrition 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 239000009405 Ashwagandha Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- IRJNJBIOUYJBHG-UHFFFAOYSA-P CN1CCCC1c1cccnc1.[H+].[H][N+]1(C)CCCC1c1cccnc1 Chemical compound CN1CCCC1c1cccnc1.[H+].[H][N+]1(C)CCCC1c1cccnc1 IRJNJBIOUYJBHG-UHFFFAOYSA-P 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 240000007582 Corylus avellana Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 244000255365 Kaskarillabaum Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241000768444 Magnolia obovata Species 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 241000531303 Mentha x rotundifolia Species 0.000 description 1
- 235000009665 Mentha x villosa Nutrition 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 241001529734 Ocimum Species 0.000 description 1
- 240000004737 Ocimum americanum Species 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 235000004195 Ocimum x citriodorum Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000016374 Perilla frutescens var crispa Nutrition 0.000 description 1
- 235000015640 Perilla frutescens var frutescens Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000011552 Rhamnus crocea Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241001312569 Ribes nigrum Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 240000000143 Turnera diffusa Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 244000002783 Vanda tricolor Species 0.000 description 1
- 241000759263 Ventia crocea Species 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 235000001978 Withania somnifera Nutrition 0.000 description 1
- 240000004482 Withania somnifera Species 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000012863 analytical testing Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 229940065144 cannabinoids Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000004952 turnera diffusa Nutrition 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- DBRXOUCRJQVYJQ-CKNDUULBSA-N withaferin A Chemical compound C([C@@H]1[C@H]([C@@H]2[C@]3(CC[C@@H]4[C@@]5(C)C(=O)C=C[C@H](O)[C@@]65O[C@@H]6C[C@H]4[C@@H]3CC2)C)C)C(C)=C(CO)C(=O)O1 DBRXOUCRJQVYJQ-CKNDUULBSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/287—Treatment of tobacco products or tobacco substitutes by chemical substances by inorganic substances only
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/12—Steaming, curing, or flavouring tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/18—Other treatment of leaves, e.g. puffing, crimpling, cleaning
Definitions
- the present disclosure relates to a method of processing pH-treated tobacco material, for example pH-treated tobacco granules or particles used in tobacco industry products.
- the present disclosure relates to a pH-treated tobacco material obtained from said method, as well as a method of storing pH-treated tobacco material, and a storage container obtained from said method.
- Tobacco industry products include smoking articles such as cigarettes, cigars and the like, which burn tobacco during use, as well as alternatives that release compounds from smokeable material without combusting. Examples of such products are tobacco heating devices or products which release compounds by heating, instead of burning.
- Tobacco industry products also include electronic aerosol provision systems which generally contain a cartomizer with a reservoir of a liquid formulation, and/or a substrate material such as a tobacco-based product, from which aerosol or vapor is generated for inhalation by a user, for example through heat vaporization.
- nicotine and often flavorants or flavor agents are present in the liquid of the reservoir and/or the substrate material. However in some countries, local regulations or other reasons such as sensory or otherwise mean that nicotine can only be present in the substrate material.
- an aerosol provision system will typically comprise a cartomizer with an aerosol or vapor generating element (a vaporizer), e.g. a heater, arranged to aerosolize a portion of precursor material to generate aerosol in an aerosol generation chamber, and a substrate material containing nicotine.
- a vaporizer e.g. a heater
- the substrate material is often heated by the aerosol or vapor generating element and/or by the aerosol itself, so as to extract nicotine into the aerosol inhaled by the user.
- a method of processing pH-treated tobacco material comprising contacting at least one pH-treated tobacco material with an effective amount of one or more gases, wherein the one or more gases reduce the pH of the pH-treated tobacco material, and wherein the reduction in pH of the pH-treated tobacco material is reversible.
- the one or more gases may comprise carbon dioxide.
- at least about 20% by volume of the one or more gases may be carbon dioxide.
- from about 25% to about 100% by volume of the one or more gases may be carbon dioxide.
- from about 50% to about 100% by volume of the one or more gases may be carbon dioxide.
- the one or more gases consist essentially of carbon dioxide, where the expression “consist essentially of” has its normal meaning in the art of including further components which do not materially affect the essential characteristics of the gases.
- the initial pH of the at least one pH-treated tobacco material may be greater than 7, for example from about 8 to about 10.
- the pH of the pH-treated tobacco material is reduced by the one or more gases, this reduction may be to a pH value of less than 7, for example from about 5 to about 6.5.
- any reduction in pH will be advantageous and the present disclosure is not limited to a specific reduction from the initial pH.
- a method of storing pH-treated tobacco material can comprise (i) placing pH-treated tobacco material in a storage container; and either (ii) sealing the storage container and (iii) processing the pH-treated tobacco material according to the processing method described herein, or (ii) processing the pH-treated tobacco material according to the method described herein, and (iii) sealing the storage container.
- the method can comprise (i) processing pH-treated tobacco material according to the method described herein, (ii) placing the tobacco material obtained from processing step (i) in a storage container, and (iii) sealing the storage container.
- the storage container may be a sealed container suitable for bulk storage of the pH-treated tobacco material, or a sealed packaging element suitable for individual storage of the pH-treated tobacco material.
- the terms “bulk storage” and “individual storage” are discussed further herein.
- a storage container comprising tobacco material obtained by the storage method described herein, wherein the pH of the tobacco material increases upon exposure to normal atmospheric conditions.
- FIG. 1 is a highly schematic cross-section of a storage container 1 in accordance with certain embodiments of the disclosure. As is discussed in more detail below, FIG. 1 shows a sealed storage container 1 comprising pH-treated tobacco material 2 and one or more gases 3 which consist essentially of carbon dioxide. It will be appreciated by the person skilled in the art that FIG. 1 is not drawn to scale.
- FIGS. 2 to 4 are flow-charts showing the key steps of the storage method according to certain embodiments of the disclosure.
- the present disclosure provides a method of processing pH-treated tobacco material, a tobacco material obtained by said processing method, a method of storing pH-treated tobacco material, a storage container comprising tobacco material obtained by said storage method, and the use of carbon dioxide.
- These aspects of the present disclosure are surprisingly able to improve the shelf-life or bulk storage time of pH-treated tobacco material, for example, pH-treated tobacco granules or particles used in tobacco industry products.
- tobacco industry product is intended to include:
- combustible smoking articles such as cigarettes, cigarillos, cigars, and tobacco for pipes or for roll-your-own or for make-your-own cigarettes (whether based on tobacco, tobacco derivatives, expanded tobacco, reconstituted tobacco, tobacco substitutes or other smokeable material);
- aerosol-free stimulant delivery articles such as lozenges, gums, patches, articles comprising inhalable powders, and smokeless tobacco products such as snus and snuff, wherein the stimulant may or may not comprise nicotine.
- Aerosol provision systems or devices may therefore be referred to herein as “vapor provision systems or devices”, “aerosol delivery systems or devices”, “electronic vapor provision systems or devices”, “electronic aerosol provision systems or devices”, or “e-cigarettes or electronic cigarettes”. These terms may be used interchangeably and are intended to refer to non-combustible aerosol provision systems or devices such as a heating device that releases compounds from aerosolizable material(s), e.g. tobacco material, without burning the aerosolizable material(s).
- the non-combustible aerosol provision system can include electronic cigarettes or e-cigarettes that create aerosol from aerosol precursor materials by heating or other techniques such as vibration; and hybrid systems that provide aerosol via a combination of aerosol precursor materials and solid substrate materials, for example hybrid systems containing liquid or gel precursor materials and a solid substrate material.
- the inventors recognized that a tobacco industry product containing pH-treated tobacco material often fails to provide a satisfactory experience to a user when the pH-treated tobacco material has been stored for a significant period of time prior to use. This was observed when the pH-treated tobacco was stored in bulk or in individual compartments, but was particularly prevalent after storage of the tobacco in individual compartments, and the unsatisfactory user experience was primarily due to a reduction in the amount of nicotine available.
- nicotine has two basic nitrogens and can exist in a un-protonated, a mono-protonated or a di-protonated form.
- the protonated forms are not volatile, whilst the un-protonated form is highly volatile and is readily able to enter the gas phase with a vapor pressure at 25° C. of 5.5 Pa.
- tobacco material is therefore generally pH treated before being used in tobacco industry products. The pH treatment raises the pH of the tobacco material from an acidic pH (e.g. 5.5) to an alkaline pH (e.g. 9.5) thereby deprotonating the nicotine and converting it into its volatile, free base form as shown below:
- the inventors realized, however, that the pH treatment and deprotonation of nicotine was causing significant nicotine stability issues when storing the pH-treated tobacco material for a length of time. Although the availability of nicotine from the tobacco material was improved, pH treatment simultaneously reduced the shelf-life of the tobacco due to the volatility of the free-base nicotine.
- the inventors believe that the reversible reduction in pH by the one or more gases is caused by the reversible formation of a weak acid from the gas(es) and water.
- the gas(es) used in the present method includes carbon dioxide
- the carbon dioxide is believed to react with water present in the pH-treated tobacco material and/or atmosphere so as to form carbonic acid, lowering the pH and protonating nicotine.
- the carbonic acid converts back to carbon dioxide, returning the pH towards its previous level, and deprotonating nicotine.
- the reversible formation of carbonic acid by carbon dioxide can be represented by the following equilibria:
- pH-treated tobacco material i.e. tobacco that has been subject to a pH treatment as is known in the art and described herein.
- pH treatment increases the pH of the tobacco.
- identity of the tobacco material is not, however, limited.
- tobacco material before pH treatment is referred to as “tobacco material”, “tobacco starting material” or “starting tobacco material”.
- the tobacco starting material can be any type or grade of tobacco and includes any part, such as for example, the leaves or stems, of any member of the genus Nicotiana and reconstituted materials thereof.
- the tobacco starting material is, in one embodiment, from the species Nicotiana tabacum.
- the tobacco starting material may be from one variety of tobacco or from more than one variety of tobacco. As is known in the art, the latter can be referred to as a blend. Examples of tobacco varieties which may be used include, but are not limited to, Virginia, Burley, Oriental and Rustica tobaccos.
- the tobacco starting material may also comprise tobacco of a certain grade or quality. For example, the tobacco starting material may comprise tobacco of high, medium and/or low grade.
- the tobacco starting material may be subjected to known practices such as drying and curing. In one embodiment the tobacco starting material is cured prior to any pH-treatment.
- the tobacco starting material can also be in any suitable form.
- the tobacco starting material can be solid, liquid or gel. In one embodiment the tobacco starting material is a solid or a gel. In one embodiment the tobacco starting material is a solid. In another embodiment the tobacco starting material is in the form of a gel. In one embodiment the tobacco starting material is a solid and selected from cut-rag, ground tobacco or baled leaf.
- the tobacco starting material is pre-treated or pre-processed into particles, beads, granules or extrudates of the desired size, and then subjected to pH treatment.
- the tobacco starting material may be ground into particles and then pH-treated as shown in FIG. 1 of WO2019016535.
- the nicotine content of the tobacco starting material is not limited and depends on the desired dosage when the nicotine is aerosolized and inhaled by a user. Generally the nicotine content is between about 0.2 wt % and about 6 wt %, on a dry weight basis relative to the total weight of the tobacco starting material. All of the wt % values for the amount of nicotine are on a dry weight basis.
- nicotine is present in an amount of no greater than about 6 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 6 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 6 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 6 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1.8 to about 6 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of no greater than about 5 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 5 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 5 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 5 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1.8 to about 5 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of no greater than about 4 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 4 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 4 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 4 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1.8 to about 4 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of no greater than about 3 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 3 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 3 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 3 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1.8 to about 3 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of no greater than about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of no greater than about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.5 to about 1.9 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of from about 0.5 to about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to about 1.8 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of less than about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of less than about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to less than about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.4 to less than about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.5 to less than about 1.9 wt % based on the total weight of the tobacco starting material.
- nicotine is present in an amount of from about 0.5 to less than about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to less than about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 0.8 to less than about 1.8 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to less than about 1.9 wt % based on the total weight of the tobacco starting material. In one embodiment nicotine is present in an amount of from about 1 to less than about 1.8 wt % based on the total weight of the tobacco starting material.
- the tobacco starting material or pH-treated tobacco material can include one or more further components.
- Such further components may be conventional in the sense that they are typically included in tobacco material or pH-treated tobacco material for tobacco industry products.
- the one or more further components include an active agent other than nicotine.
- This active agent can be a compound which has a biological effect on a user when inhaled, and may, for example, may be selected from botanicals or mixtures thereof, which are synthetic or natural in origin.
- the active agent may be a physiologically active material, which is a material intended to achieve or enhance a physiological response.
- the active substance may for example be selected from nutraceuticals, nootropics and psychoactives.
- the active substance may be naturally occurring or synthetically obtained.
- the active substance may comprise for example nicotine, caffeine, taurine, theine, vitamins such as B6 or B12 or C, melatonin, cannabinoids, or constituents, derivatives, or combinations thereof.
- the active substance may comprise one or more constituents, derivatives or extracts of tobacco, cannabis or another botanical.
- the active substance comprises nicotine. In some embodiments, the active substance comprises caffeine, melatonin or vitamin B12.
- the active substance may comprise or be derived from one or more botanicals or constituents, derivatives or extracts thereof.
- botanical includes any material derived from plants including, but not limited to, extracts, leaves, bark, fibres, stems, roots, seeds, flowers, fruits, pollen, husk, shells or the like.
- the material may comprise an active compound naturally existing in a botanical, obtained synthetically.
- the material may be in the form of liquid, gas, solid, powder, dust, crushed particles, granules, pellets, shreds, strips, sheets, or the like.
- Example botanicals are tobacco, eucalyptus , star anise, hemp, cocoa, cannabis , fennel, lemongrass, peppermint, spearmint, rooibos, chamomile, flax, ginger, Ginkgo biloba , hazel, hibiscus, laurel, licorice (liquorice), matcha, mate, orange skin, papaya , rose, sage, tea such as green tea or black tea, thyme, clove, cinnamon, coffee, aniseed (anise), basil, bay leaves, cardamom, coriander, cumin, nutmeg, oregano, paprika, rosemary, saffron, lavender, lemon peel, mint, juniper, elderflower, vanilla, wintergreen, beefsteak plant, curcuma , turmeric, sandalwood, cilantro, bergamot, orange blossom, myrtle, cassis, valerian, pimento, mace, damien, marjoram
- the mint may be chosen from the following mint varieties: Mentha arventis, Mentha c.v., Mentha niliaca, Mentha piperita, Mentha piperita citrata c.v., Mentha piperita c.v., Mentha spicata crispa, Mentha cardifolia, Memtha longifolia, Mentha suaveolens variegata, Mentha pulegium, Mentha spicata c.v. and Mentha suaveolens.
- the active substance comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is tobacco.
- the active substance comprises or derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from eucalyptus , star anise, cocoa and hemp.
- the active substance comprises or derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from rooibos and fennel.
- the one or more further components may also include one or more flavors or flavoring agents.
- flavors or flavoring agents are known in the art, and may be inherently present in the tobacco starting material or may be added to the tobacco starting material or pH-treated tobacco material.
- flavor and flavorant refer to materials which, where local regulations permit, may be used to create a desired taste, aroma or other somatosensorial sensation in a product for adult consumers.
- flavors or flavoring agents may be selected from the group consisting of liquorice, hydrangea , Japanese white bark magnolia leaf, chamomile, fenugreek, clove, menthol, Japanese mint, aniseed, cinnamon, herb, wintergreen, cherry, berry, peach, apple, spearmint, peppermint, lavender, cardamom, celery, cascarilla, Drambuie, bourbon, scotch, whiskey, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, cassia , caraway, cognac, jasmine, ylang-ylang, sage, fennel, piment, ginger, anise, coriander, coffee, flavor enhancers, bitterness receptor site blockers, sensorial receptor site activators or stimulators, sugars and/or sugar substitutes (
- sucralose acesulfame potassium, aspartame, saccharine, cyclamates, lactose, sucrose, glucose, fructose, sorbitol, or mannitol), and other additives such as charcoal, chlorophyll, minerals, botanicals, or breath freshening agents.
- the flavor(s) or flavoring agent(s) may be imitation, synthetic or natural ingredients or blends thereof, and may be in any suitable form, for example, oil, liquid, or powder, or liquid such as an oil, solid such as a powder or gas. It will be understood by the skilled person that the flavor(s) or flavoring agent(s) may be a multi-component flavor or flavoring agent or a single component flavor or flavoring agent.
- the flavor comprises menthol, spearmint and/or peppermint. In some embodiments, the flavor comprises flavor components of cucumber, blueberry, citrus fruits and/or red berry. In some embodiments, the flavor comprises eugenol. In some embodiments, the flavor comprises flavor components extracted from tobacco. In some embodiments, the flavor comprises flavor components extracted from cannabis.
- the flavor may comprise a sensate, which is intended to achieve a somatosensorial sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect.
- a sensate which is intended to achieve a somatosensorial sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect.
- a suitable heat effect agent may be, but is not limited to, vanillyl ethyl ether and a suitable cooling agent may be, but not limited to eucalyptol, WS-3.
- the pH-treated tobacco material does not undergo any further treatment.
- the tobacco starting material or pH-treated tobacco material does not contain any added acid(s). In one embodiment the tobacco starting material or pH-treated tobacco material does not contain any added organic acid selected from the group consisting of benzoic acid, levulinic acid, malic acid, maleic acid, fumaric acid, citric acid, lactic acid, acetic acid, succinic acid, and mixtures thereof.
- pH-treated tobacco material As discussed above, the terms “pH-treated tobacco material”, “pH-treated tobacco substrate” and “pH-treated tobacco” are used interchangeably herein to refer to a tobacco starting material which has undergone a treatment so as to increase its pH.
- the level of increase is not limited because it will depend on the initial pH of the tobacco starting material, and this depends on numerous factors including for example, the type of tobacco, pH treatment agent and the relative amounts of the tobacco starting material and pH treatment agent.
- the pH-treated tobacco material may be in any form, e.g. solid, liquid or gel. In one embodiment the pH-treated tobacco material is a solid or a gel. In another embodiment the pH-treated tobacco material is a solid. In another embodiment the pH-treated tobacco material is a gel.
- the form of the tobacco material is discussed in detail above (including the formation of particles, granules, beads and extrudates by methods known in the art and discussed in WO2019016535) and the skilled person would understand that the form of the tobacco starting material dictates the form of the pH-treated tobacco material.
- the pH treatment modifies the pH of the tobacco starting material from an acidic pH (less than 7) to an alkaline pH (greater than 7). In another embodiment the pH treatment modifies the pH so that the nicotine present in the tobacco starting material is deprotonated.
- suitable techniques to detect the nicotine protonation and/or deprotonation level(s), e.g. 1 H NMR spectroscopy, and thus be able to readily monitor and control the pH treatment.
- the normal, unadjusted pH of cured tobacco is slightly acidic, usually within the range of about 4.5 to about 6.5 and frequently approximately 5, for example 5.5.
- a pH treatment will then increase the pH to a basic pH of greater than 7.
- the pH treatment modifies the pH of the tobacco starting material from a pH in the range of about 4 to less than 7, to a pH of greater than 7.
- the pH treatment modifies the pH of the tobacco starting material from a pH in the range of about 5 to less than 7, to a pH of greater than 7.
- the pH of tobacco is measured using the CORESTA Recommended Method No. 69, “Determination of pH of Tobacco and Tobacco Products” (2017).
- This Recommended Method is applicable for the determination of pH in tobacco and tobacco products that are in the range 4 to 10, and involves preparing an aqueous extract of the tobacco or tobacco product sample and its pH determined using a pH electrode.
- the CORESTA Recommended Method No. 69, “Determination of pH of Tobacco and Tobacco Products” (2017) is incorporated herein by reference.
- the pH-treated tobacco material has a pH of about 7 to about 14. In another embodiment the pH-treated tobacco material has a pH of about 7 to about 13. In another embodiment the pH-treated tobacco material has a pH of about 7 to about 12. In another embodiment the pH-treated tobacco material has a pH of about 7 to about 11. In another embodiment the pH-treated tobacco material has a pH of about 7 to about 10.
- the pH-treated tobacco material has a pH of greater than about 8. In another embodiment the pH-treated tobacco material has a pH of about 8 to about 14. In another embodiment the pH-treated tobacco material has a pH of about 8 to about 13. In another embodiment the pH-treated tobacco material has a pH of about 8 to about 12. In another embodiment the pH-treated tobacco material has a pH of about 8 to about 11. In another embodiment the pH-treated tobacco material has a pH of about 8 to about 10.
- the pH-treated tobacco material has a pH of about 9.5.
- the pH-treated tobacco material has a pH of about 8.5.
- the pH treatment can, for example, involve applying a basic solution to the tobacco starting material. Such a method is described in WO2015025158 and is incorporated herein by reference.
- the basic solution can be an aqueous sodium carbonate solution or any other suitable basic solution such as sodium hydroxide or sodium phosphate.
- the pH treatment can also follow pre-processing or pre-treatment of the tobacco starting material into a form with reduced particle size as described in WO2019016535.
- the tobacco material may be dried to a particular moisture content. Such drying methods are known in the art along with desirable moisture contents, the latter typically depending on the application of the tobacco material.
- the tobacco material may be left to cool for a period of time, without external application of refrigeration or the like.
- the present disclosure relies on contacting pH-treated tobacco material as described herein with an effective amount of one or more gases, wherein the one or more gases reduce the pH of the pH-treated tobacco material, and wherein the reduction in pH of the pH-treated tobacco material is reversible.
- the effective amount of one or more gases is an amount suitable to reduce the initial pH of the pH-treated tobacco material by at least 0.1 pH. In another embodiment the reduction is at least 0.3 pH. In another embodiment the reduction is at least 0.5 pH. In another embodiment the reduction is at least 1 pH. In one embodiment the reduction is such that the pH-treated tobacco material has a pH of less than about 7, i.e. an acidic pH. Using routine techniques, the skilled person would be able to determine such an amount of the one or more gases being used.
- reversible has its normal meaning in the art, i.e. the reduction in pH caused by the one or more gases can be readily reversed so as to at least partially restore the pH-treated tobacco material to its initial pH. For example, if the one or more gases reduce the pH of the pH-treated tobacco material from about 9.5 to about 5.5, this reduction can be reversed to return the pH of the pH-treated tobacco material to about 7.5 or about 8.5.
- the reversal is at least about 50%, i.e. the reduction in pH is restored by at least about 50%.
- the reversal is at least about 60% or at least about 75% or at least about 80%.
- the reversal is at least about 90% or at least about 95%. In one embodiment the reversal is about 100%.
- the reversible nature of the pH reduction in the present disclosure is particularly advantageous because it means that the nicotine is only converted to its volatile, free base form when the pH-treated tobacco material is exposed to normal atmospheric conditions (e.g. air). It also reduces the loss of available nicotine because the processing method does not have a permanent impact or effect on the nicotine in the pH-treated material.
- the present disclosure can also be readily applied to bulk storage and individual (e.g. blister, capsule etc.) storage of the pH-treated tobacco material.
- the one or more gases comprise carbon dioxide. In an alternative embodiment, the one or more gases consist essentially of carbon dioxide. In a further alternative embodiment, the one or more gases consist of carbon dioxide; i.e. the gas is carbon dioxide.
- the one or more gases comprise at least 20% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 25% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 30% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 35% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 40% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 45% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 50% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 55% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 60% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 65% by volume carbon dioxide.
- the one or more gases comprise at least 70% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 75% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 80% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 85% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 90% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 95% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 97% by volume carbon dioxide. In one embodiment, the one or more gases comprise at least 99% by volume carbon dioxide.
- the one or more gases comprise from about 20% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 25% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 30% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 35% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 40% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 45% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 50% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 55% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 60 to about 100% by volume carbon dioxide.
- the one or more gases comprise from about 65% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 70% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 75% to about 100% by volume carbon dioxide. In one embodiment, the one or more gases comprise from about 80% to about 100% by volume carbon dioxide.
- the pH-treated tobacco material has a pH of greater than 7 and the one or more gases comprise from about 25% to about 100% by volume carbon dioxide.
- the pH-treated tobacco material has a pH of greater than 7 and the one or more gases consist essentially of carbon dioxide.
- the pH-treated tobacco material has a pH of greater than 7 and the one or more gases comprise from about 50% to about 100% by volume carbon dioxide.
- the reduction in pH by the one or more gases is not specifically limited. It will depend on the pH of the pH-treated tobacco material and on the one or more gases being used, amongst other factors. Given the effect of the reduction in pH—namely the protonation of nicotine—the pH of the pH-treated tobacco material is, in one embodiment, reduced to an acidic pH, i.e. a pH of less than 7.
- the reduction in pH by the one or more gases is about 0.1 pH. In another embodiment the reduction in pH is about 0.2 pH. In another embodiment the reduction in pH is about 0.3 pH. In another embodiment the reduction in pH is about 0.4 pH. In another embodiment the reduction in pH is about 0.5 pH. In another embodiment the reduction in pH is about 1.0 pH. In another embodiment the reduction in pH is about 1.5 pH. In another embodiment the reduction in pH is about 2.0 pH. In another embodiment the reduction in pH is about 2.5 pH. In another embodiment the reduction in pH is about 3.0 pH.
- the one or more gases reduce the pH of the pH-treated tobacco material to less than 7. In one embodiment the one or more gases reduce the pH of the pH-treated tobacco material to less than about 6.5. In one embodiment the one or more gases reduce the pH of the pH-treated tobacco material to less than about 6. In one embodiment the one or more gases reduce the pH of the pH-treated tobacco material to less than about 5. In one embodiment the one or more gases reduce the pH of the pH-treated tobacco material to less than about 4. In one embodiment the pH of the pH-treated tobacco material is reduced by the one or more gases to about 5.5.
- the present disclosure also provides a tobacco material obtained by the method described herein.
- the tobacco material obtained by the processing method differs from those of the art at least by the interaction of the one or more gases (e.g. carbon dioxide) with the material and the reversible modification of the pH.
- the one or more gases e.g. carbon dioxide
- the inventors believe that there is an interaction between the one or more gases and water present in the pH-treated tobacco material and/or atmosphere which results in the formation of a weak acid, lowering the pH and protonating nicotine.
- This pH modification is, however, reversible in that on exposure of the tobacco to normal atmospheric conditions, it returns towards its initial value.
- the tobacco material obtained by the processing method is therefore unique at least due to its “dynamic” pH. At the molecular level the tobacco material will also differ from known tobacco because of the interaction of the one or more gas(es) with the tobacco surface.
- the present disclosure provides a method of storing pH-treated tobacco material.
- the method has at least three possible configurations and the key steps of these configurations are set out as flow-charts in FIGS. 2, 3 and 4 .
- the method may comprise (i) placing the pH-treated tobacco material in a storage container, (ii) sealing the storage container, and (iii) processing the pH-treated tobacco material according to the method described herein. This configuration is shown in FIG. 2 .
- the method may comprise (i) placing the pH-treated tobacco material in a storage container, (ii) processing the pH-treated tobacco material according to the method described herein, and (iii) sealing the storage container. This configuration is shown in FIG. 3 .
- the method may comprise (i) processing the pH-treated tobacco material according to the method described herein, (ii) placing the tobacco material obtained from processing step (i) in a storage container and (iii) sealing the storage container. This configuration is shown in FIG. 4 .
- FIG. 1 is a schematic cross-sectional view of an example storage container. It includes a storage container 1 comprising pH-treated tobacco material 2 and one or more gases 3 which consist essentially of carbon dioxide. As would be understood by the skilled person, the one or more gases may be as defined above.
- the example storage container of FIG. 1 may be prepared by placing pH-treated tobacco material in the storage container, sealing the storage and then contacting the pH-treated tobacco material with an effective amount of one or more gases, wherein the one or more gases reduce the pH of the pH-treated tobacco material, and wherein the reduction in pH of the pH-treated tobacco material is reversible, i.e. processing the pH-treated tobacco material according to the method described herein (see FIG. 2 ).
- the example storage container of FIG. 1 may be prepared by placing pH-treated tobacco material in the storage container, contacting the pH-treated tobacco material with an effective amount of one or more gases, wherein the one or more gases reduce the pH of the pH-treated tobacco material, and wherein the reduction in pH of the pH-treated tobacco material is reversible (i.e. processing the pH-treated tobacco material according to the method described herein), and then sealing the storage container ( FIG. 3 ).
- the example storage container of FIG. 1 may be prepared by contacting the pH-treated tobacco material with an effective amount of one or more gases, wherein the one or more gases reduce the pH of the pH-treated tobacco material, and wherein the reduction in pH of the pH-treated tobacco material is reversible (i.e. processing the pH-treated tobacco material according to the method described herein), placing the pH-treated tobacco material in the storage container and sealing the storage container ( FIG. 4 ).
- the present disclosure further provides a storage container obtained by said storage method.
- An example storage container is shown in FIG. 1 ; although the skilled person will appreciate that the present disclosure is not limited to the specific arrangement shown in FIG. 1 . This figure is just provided by way of example.
- the storage container can be an apparatus or a container used for bulk storage, such as a sealed bag, box or the like.
- the storage container can also be an apparatus or container used for storage of pH-treated tobacco material on a smaller scale, this type of storage is referred to herein as “individual storage” because it is intended to refer to storage of consumer portions or individual portions of tobacco rather than larger quantities stored during shipment etc.
- the individual storage is a blister pack where each blister contains a single dosage or portion of the tobacco material.
- the individual storage is a tobacco pod.
- the storage container is a sealed container.
- the sealing of the container is not limited and can be achieved by any method known in the art which results in an air-tight seal.
- the storage container is a hermetically sealed container.
- the store is a sealed blister in a blister pack or a sealed tobacco pod. Again the sealing can be achieved by any method known in the art which results in an air-tight seal.
- the present disclosure further provides the use of carbon dioxide to increase the shelf-life or bulk storage time of pH-treated tobacco material.
- bulk storage time is meant the time when the pH-treated tobacco material is subject to bulk storage or stored in bulk, e.g. during shipment.
- shelf-life is meant the time when the pH-treated tobacco material is available to a user, e.g. the time when the product is available for purchase and use.
- the present disclosure provides an improvement in both scenarios.
- CORESTA Recommended Method No. 81 (June 2015) is entitled “Routine Analytical Machine for E-Cigarette Aerosol Generation and Collection—Definitions and Standard Conditions”, and includes the requirements needed for generation and collection of e-cigarette aerosol for analytical testing purposes.
- CORESTA Recommended Method No. 84 (June 2017) is entitled “Determination of Glycerin, Propylene Glycol, Water, and Nicotine in the Aerosol of E-Cigarettes by Gas Chromatographic Analysis” and refers to the CORESTA Recommended Method No. 81 (June 2015).
- CORESTA Recommended Method No. 84 details how aerosol is generated and collected from electronic cigarettes by a standard procedure.
- Aerosol collected mass may be determined gravimetrically, and results are expressed as the weight of analyte collected per device, per weight of collected aerosol, per puff, or per puff set as warranted.
- the equipment and reagents for the analysis, including the gas chromatography analysis, are detailed in the CORESTA Method.
- the blend and/or aerosol nicotine is measured in the present disclosure according to the above-mentioned CORESTA methods, namely CORESTA Recommended Method Nos. 81, 84 and 62. These CORESTA methods are therefore incorporated herein by reference.
- an increase in shelf-life or bulk storage time can be determined by measuring the blend nicotine or aerosol nicotine of a pH-treated tobacco material stored under carbon dioxide, and comparing it with the blend or aerosol nicotine of a pH-treated tobacco material not stored under carbon dioxide, e.g. stored in air.
- all variables should be kept constant except for the storage environment. For example, two samples of a pH-treated tobacco material could be stored under ambient temperature and pressure for 3 months, one could be stored under air and one could be stored under carbon dioxide.
- the blend nicotine and/or aerosol nicotine could then be measured according to the above-described CORESTA methods for both samples and their comparison would demonstrate whether the shelf-life and storage time had been improved (i.e. increased) by the present disclosure.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Manufacture Of Tobacco Products (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1903083.2 | 2019-03-07 | ||
GBGB1903083.2A GB201903083D0 (en) | 2019-03-07 | 2019-03-07 | Tobacco processing method |
PCT/GB2020/050355 WO2020178546A1 (en) | 2019-03-07 | 2020-02-14 | Tobacco processing method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220125097A1 true US20220125097A1 (en) | 2022-04-28 |
Family
ID=66380339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/436,846 Pending US20220125097A1 (en) | 2019-03-07 | 2020-02-14 | Tobacco processing method |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220125097A1 (ja) |
EP (1) | EP3934457A1 (ja) |
JP (1) | JP7395602B2 (ja) |
KR (1) | KR102662254B1 (ja) |
GB (1) | GB201903083D0 (ja) |
WO (1) | WO2020178546A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202014921D0 (en) * | 2020-09-22 | 2020-11-04 | Nicoventures Trading Ltd | Tobacco compositions and preparation thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080173317A1 (en) * | 2006-08-01 | 2008-07-24 | John Howard Robinson | Smokeless tobacco |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009015142A2 (en) | 2007-07-23 | 2009-01-29 | R.J.Reynolds Tobacco Company | Smokeless tobacco compositions and methods for treating tobacco for use therein |
US8061362B2 (en) | 2007-07-23 | 2011-11-22 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
EP2720567B1 (en) | 2011-06-15 | 2017-11-15 | JT International SA | Tobacco packaging having a controlled internal environment |
GB201314917D0 (en) | 2013-08-21 | 2013-10-02 | British American Tobacco Co | Treated Tobacco and processes for preparing the same, Devices including the same and uses thereof |
GB201711534D0 (en) | 2017-07-18 | 2017-08-30 | British American Tobacco Investments Ltd | Tobacco constituent releasing components |
-
2019
- 2019-03-07 GB GBGB1903083.2A patent/GB201903083D0/en not_active Ceased
-
2020
- 2020-02-14 US US17/436,846 patent/US20220125097A1/en active Pending
- 2020-02-14 JP JP2021552925A patent/JP7395602B2/ja active Active
- 2020-02-14 WO PCT/GB2020/050355 patent/WO2020178546A1/en active Application Filing
- 2020-02-14 KR KR1020217031987A patent/KR102662254B1/ko active IP Right Grant
- 2020-02-14 EP EP20707790.0A patent/EP3934457A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080173317A1 (en) * | 2006-08-01 | 2008-07-24 | John Howard Robinson | Smokeless tobacco |
Also Published As
Publication number | Publication date |
---|---|
WO2020178546A1 (en) | 2020-09-10 |
JP2022524353A (ja) | 2022-05-02 |
EP3934457A1 (en) | 2022-01-12 |
KR102662254B1 (ko) | 2024-04-29 |
KR20210134750A (ko) | 2021-11-10 |
GB201903083D0 (en) | 2019-04-24 |
JP7395602B2 (ja) | 2023-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019370810B2 (en) | Aerosolised formulation | |
US20210177040A1 (en) | Aerosolizable formulation | |
AU2019370809B2 (en) | Aerosolisable formulation | |
US20210386111A1 (en) | Aerosolisable formulation | |
CN113163840A (zh) | 气雾化配制品 | |
US20220125097A1 (en) | Tobacco processing method | |
US20240074487A1 (en) | Aerosol-generating material and uses thereof | |
US20220183343A1 (en) | A consumable for an aerosol provision system | |
US20240090562A1 (en) | A dried aerosol-generating material and uses thereof | |
RU2785541C2 (ru) | Превращенная в аэрозоль композиция | |
US20230157350A1 (en) | Delivery systems and methods of making the same | |
US20240041092A1 (en) | Aerosol generating material | |
WO2023187397A1 (en) | A composition comprising an aerosol-generating material and sorbent material, and uses thereof | |
WO2023187403A1 (en) | Aerosol-generating compositions and uses thereof | |
WO2023233128A1 (en) | Sheet material with desiccant properties and uses thereof | |
WO2023026048A1 (en) | Aerosol-generating material | |
WO2023187411A1 (en) | A substrate comprising an aerosol-generating material surrounded by a support and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: NICOVENTURES TRADING LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ESSEN, TOMAS;BISHOP, DAVID;WOODCOCK, DOMINIC CONRAD;SIGNING DATES FROM 20210920 TO 20211011;REEL/FRAME:061388/0082 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |